Skip to main content

Table 1 Tigecycine MICs of isolates obtained by different testing methodologies or medium types

From: Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline

  Number of isolates with MICs (mg l− 1)
Organism (n) Method <0. 1 0.1 0.2 0.5 1 2 4 8 16 32 64
All isolates (84) BMD1 2 10 20 13 19 4 7 7 1 1 0
BMD2 0 6 19 12 14 15 7 7 3 1 0
Etest 2 15 24 8 12 7 8 7 1 0 0
AD 0 1 11 17 16 13 11 2 9 3 1
K. pneumoniae (29) BMD1 0 0 3 4 10 2 2 6 1 1 0
BMD2 0 0 2 2 6 7 2 6 3 1 0
Etest 0 0 6 5 7 1 3 6 1 0 0
AD 0 0 0 2 6 9 2 2 7 0 1
E. coli (30) BMD1 0 7 14 8 1 0 0 0 0 0 0
BMD2 0 3 13 9 4 1 0 0 0 0 0
Etest 1 10 16 2 1 0 0 0 0 0 0
AD 0 1 8 11 9 1 0 0 0 0 0
A. baumannii (25) BMD1 2 3 3 1 8 2 5 1 0 0 0
BMD2 0 3 4 1 4 7 5 1 0 0 0
Etest 1 5 2 1 4 6 5 1 0 0 0
AD 0 0 3 4 1 3 9 0 2 3 0
  1. BMD1 Broth microdilution –Difco, BMD2 Broth microdilution -Condalab, AD Agar dilution